Perform Another (Advanced) Search

1. Advanced/Specific Search Results XENICAL [ORLISTAT]
...Advanced/Specific Search Results XENICAL [ORLISTAT] Clinical Trial Results: XENICAL [ORLISTAT] Product Name: XENICAL [ORLISTAT] Date of Report: To be Published Phase: III A study of ...
View Page

2. Clinical Trial Results: Obesity
...Clinical Trial Results: Obesity Clinical Trial Results: Obesity Product Name: Xenical [orlistat] Date of Report: 8/21/2002 Phase: III (XENDOS study) Weight Reducing and Type 2 Diabetes Preventing Effects of Xenical in Obese Patients Product Name: Xenical [orlistat] Date of Report: 6/13/2003 Phase: IV Effect of orlistat in the prevention of ...
View Page

3.  Newly Approved Drug Therapies (566) Xenical/Orlistat Capsules, Roche,
...Newly Approved Drug Therapies (566) Xenical/Orlistat Capsules, Roche, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Xenical/Orlistat Capsules Company: Roche Approval Status: Approved April 1999 Treatment Area: Endocrinology General Information Xenical/Orlistat ...
View Page

4.  Study Posting (4519) Trial #156316, Obesity, Yaroslavl, Russian Federation
...Study Posting (4519) Trial #156316, Obesity, Yaroslavl, Russian Federation Trial Information A study of Xenical (Orlistat) in Overweight and Obese Adolescents Status: Recruiting Protocol Number: ML19569 Sponsor: Hoffmann-La Roche Company ...
...Pharmaceutical Official Scientific Title: Open-label comparative randomized study of the efficacy and safety of orlistat (Xenical) in complex therapy of obesity and metabolic disorders in adolescents Brief Summary: This 2 ...
View Page

5.  Study Posting (4519) Trial #156284, Obesity, Tumen, Russian Federation
...Study Posting (4519) Trial #156284, Obesity, Tumen, Russian Federation Trial Information A study of Xenical (Orlistat) in Overweight and Obese Adolescents Status: Recruiting Protocol Number: ML19569 Sponsor: Hoffmann-La Roche Company ...
...Pharmaceutical Official Scientific Title: Open-label comparative randomized study of the efficacy and safety of orlistat (Xenical) in complex therapy of obesity and metabolic disorders in adolescents Brief Summary: This 2 ...
View Page

6.  Study Posting (4519) Trial #156199, Obesity, Samara, Russian Federation
...Study Posting (4519) Trial #156199, Obesity, Samara, Russian Federation Trial Information A study of Xenical (Orlistat) in Overweight and Obese Adolescents Status: Recruiting Protocol Number: ML19569 Sponsor: Hoffmann-La Roche Company ...
...Pharmaceutical Official Scientific Title: Open-label comparative randomized study of the efficacy and safety of orlistat (Xenical) in complex therapy of obesity and metabolic disorders in adolescents Brief Summary: This 2 ...
View Page

7.  Study Posting (4519) Trial #156348, Obesity, Novosibirsk, Russian Federation
...Study Posting (4519) Trial #156348, Obesity, Novosibirsk, Russian Federation Trial Information A study of Xenical (Orlistat) in Overweight and Obese Adolescents Status: Recruiting Protocol Number: ML19569 Sponsor: Hoffmann-La Roche Company ...
...Pharmaceutical Official Scientific Title: Open-label comparative randomized study of the efficacy and safety of orlistat (Xenical) in complex therapy of obesity and metabolic disorders in adolescents Brief Summary: This 2 ...
View Page

8.  Study Posting (4519) Trial #156148, Obesity, Moscow, Russian Federation
...Study Posting (4519) Trial #156148, Obesity, Moscow, Russian Federation Trial Information A study of Xenical (Orlistat) in Overweight and Obese Adolescents Status: Recruiting Protocol Number: ML19569 Sponsor: Hoffmann-La Roche Company ...
...Pharmaceutical Official Scientific Title: Open-label comparative randomized study of the efficacy and safety of orlistat (Xenical) in complex therapy of obesity and metabolic disorders in adolescents Brief Summary: This 2 ...
View Page

9.  Study Posting (4519) Trial #156373, Obesity, Krasnoyarsk, Russian Federation
...Study Posting (4519) Trial #156373, Obesity, Krasnoyarsk, Russian Federation Trial Information A study of Xenical (Orlistat) in Overweight and Obese Adolescents Status: Recruiting Protocol Number: ML19569 Sponsor: Hoffmann-La Roche Company ...
...Pharmaceutical Official Scientific Title: Open-label comparative randomized study of the efficacy and safety of orlistat (Xenical) in complex therapy of obesity and metabolic disorders in adolescents Brief Summary: This 2 ...
View Page

10.  Study Posting (4519) Trial #156272, Obesity, Krasnodar, Russian Federation
...Study Posting (4519) Trial #156272, Obesity, Krasnodar, Russian Federation Trial Information A study of Xenical (Orlistat) in Overweight and Obese Adolescents Status: Recruiting Protocol Number: ML19569 Sponsor: Hoffmann-La Roche Company ...
...Pharmaceutical Official Scientific Title: Open-label comparative randomized study of the efficacy and safety of orlistat (Xenical) in complex therapy of obesity and metabolic disorders in adolescents Brief Summary: This 2 ...
View Page

11.  Study Posting (4519) Trial #156372, Obesity, Khabarovsk, Russian Federation
...Study Posting (4519) Trial #156372, Obesity, Khabarovsk, Russian Federation Trial Information A study of Xenical (Orlistat) in Overweight and Obese Adolescents Status: Recruiting Protocol Number: ML19569 Sponsor: Hoffmann-La Roche Company ...
...Pharmaceutical Official Scientific Title: Open-label comparative randomized study of the efficacy and safety of orlistat (Xenical) in complex therapy of obesity and metabolic disorders in adolescents Brief Summary: This 2 ...
View Page

12.  Study Posting (4519) Trial #156184, Obesity, Kazan, Russian Federation
...Study Posting (4519) Trial #156184, Obesity, Kazan, Russian Federation Trial Information A study of Xenical (Orlistat) in Overweight and Obese Adolescents Status: Recruiting Protocol Number: ML19569 Sponsor: Hoffmann-La Roche Company ...
...Pharmaceutical Official Scientific Title: Open-label comparative randomized study of the efficacy and safety of orlistat (Xenical) in complex therapy of obesity and metabolic disorders in adolescents Brief Summary: This 2 ...
View Page

13.  Study Posting (4519) Trial #156144, Obesity, Ekaterinburg, Russian Federation
...Study Posting (4519) Trial #156144, Obesity, Ekaterinburg, Russian Federation Trial Information A study of Xenical (Orlistat) in Overweight and Obese Adolescents Status: Recruiting Protocol Number: ML19569 Sponsor: Hoffmann-La Roche Company ...
...Pharmaceutical Official Scientific Title: Open-label comparative randomized study of the efficacy and safety of orlistat (Xenical) in complex therapy of obesity and metabolic disorders in adolescents Brief Summary: This 2 ...
View Page

14.  Study Posting (4519) Trial #156275, Obesity, Nizhny Novgorod, Russian Federation
...Posting (4519) Trial #156275, Obesity, Nizhny Novgorod, Russian Federation Trial Information A study of Xenical (Orlistat) in Overweight and Obese Adolescents Status: Recruiting Protocol Number: ML19569 Sponsor: Hoffmann-La Roche Company ...
...Pharmaceutical Official Scientific Title: Open-label comparative randomized study of the efficacy and safety of orlistat (Xenical) in complex therapy of obesity and metabolic disorders in adolescents Brief Summary: This 2 ...
View Page

15. Clinical Trial Results: Weight Loss
...Clinical Trial Results: Weight Loss Clinical Trial Results: Weight Loss Product Name: Xenical [orlistat] Date of Report: 3/24/2004 Phase: IV Cardiovascular risk reduction evaluation in obese or overweight patients with mild or moderate hypertension after taking orlistat for 9 months – multicenter and open-label study Jobson Medical Information • Privacy | • Glossary Copyright © 1995 ...
View Page

16.  Study Posting (4519) Trial #104983, Obesity, Geneve, Switzerland
...Study Posting (4519) Trial #104983, Obesity, Geneve, Switzerland Trial Information A Study of Xenical (Orlistat) in a Multi-Factorial Approach to Weight Loss Maintenance Status: Completed Protocol Number: ML16868 Sponsor ...
...Roche Pharma (Schweiz) AG Company Division: Pharmaceutical Official Scientific Title: Multi-factorial approach associated with orlistat (Xenical) for 4 years' weight loss maintenance in obese patients Brief Summary: This study will ...
View Page

17. Clinical Trial Results by Drug Names
...Results by Drug Names Clinical Trial Result Information Title of Study: A study of Xenical (Orlistat) in Overweight and Obese Adolescents Fast Facts: Protocol number: ML19569 Sponsor: Hoffmann-La Roche Company division: Pharmaceutical Product name: XENICAL Generic name: ORLISTAT Phase of development: III Therapeutic area, approved indication: Obesity Date of report: To be Published ...
View Page

18. Clinical Trial Results by Drug Names
...Clinical Trial Results by Drug Names Clinical Trial Result Information Title of Study: Effect of orlistat in the prevention of weight regain and in long-term weight maintenance in abdominally obese ...
...M37017 Sponsor: F. Hoffmann-La Roche Ltd Company division: Pharmaceutical Product name: Xenical Generic name: orlistat Phase of development: IV Therapeutic area, approved indication: Obesity Date of report: 6/13/2003 ...
View Page

19. Clinical Trial Results by Drug Names
...Results by Drug Names Clinical Trial Result Information Title of Study: A Study of Xenical (Orlistat) in a Multi-Factorial Approach to Weight Loss Maintenance Fast Facts: Protocol number: ML16868 Sponsor: Roche Pharma (Schweiz) AG Company division: Pharmaceutical Product name: Xenical Generic name: orlistat Phase of development: IV Therapeutic area, approved indication: Obesity Date of report: To be Published ...
View Page

20. Clinical Trial Results by Drug Names
...risk reduction evaluation in obese or overweight patients with mild or moderate hypertension after taking orlistat for 9 months – multicenter and open-label study Fast Facts: Protocol number: M37081 Sponsor: Produtos Roche Químicos e Farmacêuticos S.A. Company division: Pharmaceutical Product name: Xenical Generic name: orlistat Phase of development: IV Therapeutic area, approved indication: Weight Loss Date of report: 3/24 ...
View Page